FILE PHOTO: The Alzheimer’s drug LEQEMBI is seen in this undated handout image obtained by Reuters on January 20, 2023. Eisai/Handout via REUTERS THIS IMAGE HAS BEEN SUPPLIED BY A THIRD PARTY. MANDATORY CREDIT/File Photo
Want our Alerts FASTER than everyone else?
Serious traders know that every second counts in these markets. Text messages are about 7x faster than email. Get an edge on other traders by receiving our FREE instant Stock Alerts ahead of e-mail subscribers by subscribing to our Mobile Alert System.
We promise never to share your number with anyone else. Standard text messaging rates may apply.
